Leading the life sciences industry
Discover the 150+ academic medical centers, commercial labs, incubators, accelerators, and programs and services leading life sciences in New York State.
Funding
Investing in innovation
Careers
Your future starts here
The Latest
NewYorkBio Appoints 2026 Board of Directors
NewYorkBIO appointed the 2026 Board of Directors representing various sectors and share a commitment to advancing the growth of New York’s statewide life science industry.
The new class of leaders includes Andrew Lam of Ally Bridge Group,Theresa Mazzullo of Excell Partners, Monica Shaw of Bristol Myers Squibb and Julia Nanyi Zhao, PhD of BioLabs@NYU.
The following board members were reelected to serve another three-year term: Rana Al-Hallaq llaq of Pfizer Ventures, Matt Badalucco of Merck, Dawn Bell of Kardigan.Bio, Lis Leiderman, MD,
Robert Van Nostrand a Veteran Biotech CFO, Manan Shah of 1619 Advisors and Alan Tamarelli of Cooley LLP.
Governor Hochul Announces over $2 Million Renovation for State University of New York Upstate Medical Center’s CNY Biotech Accelerator in Syracuse.
Antibiotic resistance could undo a century of medical progress – but four advances are changing the story
Authored by Andre O. Hudson, Dean of the College of Science, Professor of Biochemistry, Rochester Institute of Technology, this article underscores both the urgency of the antibiotic resistance crisis and the innovations that offer real hope from faster diagnostics and novel therapeutic approaches to stronger policies and improved stewardship.
Nilo Therapeutics Wins Inaugural NewYorkBIO Impact Award Presented by New York City Economic Development Corporation
Nilo Therapeutics, an early-stage biotech company developing groundbreaking therapies for autoimmune and inflammatory diseases, was selected for its bold innovation, commitment to patient-centered science, and deep roots in the New York community. As the 2025 winner, Nilo received a $15,000 cash prize in recognition of its impact and continued potential to shape the future of health and biotechnology in the city.
2026 Medical Device Innovation Challenge Through The CNY Biotech Accelerator Now Accepting Applications
CNY Biotech Accelerator’s (CNYBAC) Medical Device Innovation Challenge (MDIC) is accepting applications for the 2026 cohort now through March 1, 2026. Eligible teams will be notified to complete supplemental questions by March 31, 2026. Learn more under Service and Programs
LIFE SCIENCES IN NEW YORK
Where science and opportunity come together
New York’s life science sector has attracted unprecedented investment, expanded research clusters across the state, and nurtured the growth of early-stage companies.
70,000
LIFE SCIENCES JOBS
25%
CLINICAL TRIALS IN THE U.S.
60%
PHARMACEUTICAL HEADQUARTERS